Nonviral Skin Gene Therapy
- 1 November 2000
- journal article
- review article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 11 (16) , 2253-2259
- https://doi.org/10.1089/104303400750035780
Abstract
Nonviral skin gene therapy is an effective method to directly deliver and transiently express genes in the skin. Several different nonviral delivery methods have been successfully used and are analyzed here for their efficiency and efficacy in achieving specific therapeutic applications. For one important and frequently used application of nonviral skin gene therapy, genetic immunization, the types of resulting immune responses (Th1 versus Th2) will depend on which delivery method is used. In addition, we discuss the contributions of DNA as an immunostimulatory adjuvant in genetic immunization and how activation of skin dendritic cells and induction of IL-12 expression are mechanistically important in this process. Nonviral skin gene therapy has also been successfully used to enhance tumor regression in animal models, frequently by inducing a specific immune response against the tumor. In the future, nonviral skin gene therapy may be successfully used for the treatment of additional skin diseases if genes can be selectively delivered and expressed in specific skin cells, and if increased level and duration of gene expression can be achieved.Keywords
This publication has 55 references indexed in Scilit:
- Genetic Immunization with Glycoprotein 63 cDNA Results in a Helper T Cell Type 1 Immune Response and Protection in a Murine Model of LeishmaniasisHuman Gene Therapy, 1998
- Enhanced Collagen Accumulation Following Direct Transfection of the Inducible Nitric Oxide Synthase Gene in Cutaneous WoundsBiochemical and Biophysical Research Communications, 1998
- Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin.Journal of Clinical Investigation, 1998
- CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvantsEuropean Journal of Immunology, 1997
- Immune Activation by Bacterial DNA: A New Genetic CodeImmunity, 1996
- Cytokine gene expression in epidermis with biological effects following injection of naked DNANature Genetics, 1995
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies.The Journal of Experimental Medicine, 1987